American Chemical Society

Dr. Irani has been Chairman and Chief Executive Officer of Occidental since 1990. He was Chief Operating Officer from 1984 to 1990. He was Chairman of the Board of Directors of Canadian Occidental Petroleum Ltd. (now Nexen Inc.) from 1987 to 1999. Dr. Irani also is a director of Wynn Resorts, Limited and TCW Group.

A highly disciplined businessman with a single-minded dream to build a great company, President and Chief Executive Officer, Rick Hudson founded RL Hudson & Company in 1980 as a seal distributorship. Since then, the company has evolved to become a global supplier of custom-molded rubber and plastic solutions for some of the worlda s largest and most well-known manufacturers. While the companya s business model has evolved, Ricka s primary goals have remained constant: to offer the best in products and services to his customers, and create outstanding opportunities for his employees. Originally from Chamblee, Georgia, a suburb of Atlanta, Rick initially attended Vanderbilt University, and then transferred to Georgia Institute of Technology where he received his undergraduate degree in industrial management, with a minor in engineering. After graduating from Georgia Tech in 1967, Rick began his career working with Parker Seal, a division of Parker Hannifin Corporation, in Culver City, California. It was there that he began to develop his passion for and knowledge of rubber and plastic technology, and the application of those materials. In 1973, Rick joined Disogrin Industries, a manufacturer of polyurethane molded products and hydraulic seals. He then launched RL Hudson & Company in 1980. Today, Rick is considered an authority on rubber and plastics, as well as the design and manufacturing of products and components that use these materials. He is frequently asked to speak to business and professional organizations, industry and technical groups, and engineering students on diverse topics including Asian supply chain management and polymer technology. In 2003, as President and Chief Executive Officer of RL Hudson & Company, Rick was honored by the Tulsa Metro Chamber of Commerce as Tulsaa s Small Business Person of the Year. The following year, he also was honored by the U.S. Small Business Administration as Oklahomaa s Small Business Person of the Year. The company also has won numerous awards for quality and reliability from its customers. Rick is very active in professional and community organizations. He is Vice-Chairman of the Tulsa Metropolitan Utility Authority, a member of the Tulsa Metro Chamber of Commerce Executive Committee and a member of the Broken Arrow Economic Development Corporation. He also serves on The University of Tulsaa s College of Business Administration Executive Advisory Board and on the Board of Directors for Triad Bank.

David gained an academic interest in mechanisms of aging and began exploring the possibility of pharmacological intervention into the aging process in 1998. Animal models indicated R-lipoic acid (RLA) may normalize several age-related markers to those of youthful animals. RLA was commercially unavailable at that time, so he began to work out industrially feasible routes to produce RLA and stable-bioavailable dosage forms on a large scale, which evolved into GeroNova Research, Inc. David has played a key role in the introduction and development of R-Lipoic Acid, K-RALA, Na-RALA, Rala-Gel and R-DHLA for the nutraceutical industry. David's latest research is the development of entirely "green" and asymmetric processes for the industrial scale synthesis of RLA and R-DHLA, and the contribution of stereochemistry and the metabolites to the overall mechanisms of action of RLA/R-DHLA. He is continuously testing and developing novel dosage forms, evaluating the plasma pharmacokinetics of RLA and various nutritional supplements and identifying new biomarkers for quantitation and intervention into the aging process. GeroNova has compiled an extensive data base of English and foreign language lipoic acid articles and is actively translating foreign articles into English in order to facilitate future researchers. David is actively involved in numerous international collaborations involving the elucidation of the mechanisms of action of RLA, new product development and clinical trials. David was an invited speaker at the Oxygen Club of California (OCC) & the Lipoic Acid workshop in Santa Barbara, CA (March 12-15, 2008) where he discussed the pharmacokinetics and pharmacodynamics of RLA in humans, the role of stereochemistry in the mechanisms of action of lipoic acid and unsolved problems in lipoic acid research. David has spoken at the American College for the Advancement of Medicine, American Association of Naturopathic Physicians (AANP) and Smart Life Forum on the use of R-Lipoic Acid & R-Dihydrolipoic acid in nutrition and clinical practice. David is a member of The American Chemical Society, The California Academy of Sciences, The New York Academy of Sciences, and the International Union of Pure and Applied Chemistry.

D. E. (Dave) Kepler is senior vice president of Shared Services, Environment, Health and Safety and chief information officer (CIO) of The Dow Chemical Company. In this capacity, Kepler has global responsibility for Customer Service, Information Systems, Purchasing, Six Sigma, Supply Chain, Work Process Improvement, and the Company's Environment, Health and Safety activities and has executive oversight for Dowa s activities in Canada. He is also a member of the Office of the Chief Executive (OCE). Kepler joined Dow in 1975 in the Western Division Computer and Process Systems group. After progressive Commercial and Information Systems roles throughout the United States, Canada and the Pacific, he was named director of Chemicals and Plastics Information Systems in 1993. In 1995, Kepler assumed additional responsibility as director of Global Information Systems Applications. He was appointed vice president and CIO in February 1998, and in 2000, assumed the role of corporate vice president of eBusiness. In 2002, Kepler undertook commercial responsibility for the Advanced Electronic Materials business and further expanded his role the following year, adding responsibility for Global Purchasing and Supply Chain. Kepler assumed his role as corporate vice president of Shared Services and chief information officer (CIO) in January 2004. He was appointed senior vice president in March 2006 and added additional responsibilities for Company's Environment, Health and Safety activities. Kepler serves on the Board of Directors of the U.S. Chamber of Commerce. He is a member of the American Chemical Society and the American Institute of Chemical Engineers. In addition, he chairs the Chemical IT Council and Cyber Security Program. Locally, Kepler serves on the Board of Directors for the Midland Community Cancer Services and Alden B. Dow Museum of Science and Art. He was the 2004 United Way of Midland County Campaign Chair. Kepler received a bachelor's degree in chemical engineering from the University of California at Berkeley.

William F. Banholzer is Executive Vice President and Chief Technology Officer of The Dow Chemical Company, located in Midland, Michigan. He is a member of Dow’s Executive Leadership Committee, Dow’s Management Committee, chairs the company’s Innovation Committee, and leads Dow’s research and development activities across the globe. Banholzer serves on Dow’s Venture Capital Board, Dow AgroSciences' Members Committee, the Dow Foundation, and the governing Council of the U.S. National Academy of Engineering. He is a member of the Board of Directors of Dow Corning Corporation and serves on that Board’s Corporate Responsibility Committee. Prior to Dow, Banholzer had a 22-year career with General Electric Company (GE), where he was vice president of Global Technology at GE Advanced Materials, responsible for worldwide technology and engineering. He joined GE in 1983 as a staff chemical engineer in the company’s Corporate Research and Development Laboratory. In 1989, he led GE R&D Center's chemical vapor deposition material program and later was promoted to laboratory manager for Advanced Inorganic Materials. In 1992, Banholzer transferred to GE's Superabrasives business, where he held numerous management positions culminating in responsibility for the division's worldwide engineering and quality efforts. Banholzer was elected a company officer and moved to GE Lighting as vice president of Global Engineering in 1997. In 1999 he transferred to GE’s Advanced Materials business as the vice president of global technology, leading a worldwide team responsible for process and product engineering, new capacity technology and product quality initiatives. During his GE career, Banholzer was honored with GE’s Bronze, Silver, and Gold Patent Awards; GE Superabrasives’ Leadership Award; GE Plastics’ CEO Six Sigma Award; and election to the Whitney Gallery of Technical Achievers. In 2002, Banholzer was elected to the U.S. National Academy of Engineering, one of the highest distinctions that can be accorded an engineer. He is one of only 105 active chemical engineers elected to the prestigious institution, which honors those who have made "important contributions to engineering theory and practice" or demonstrated "unusual accomplishment in the pioneering of new and developing fields of technology." In 2006 he was elected by the Academy membership to serve as one of 12 councillors comprising the governing body of the NAE. Banholzer serves as a presidential nominee to the MIT Corporation Visiting Committee for the Departments of Chemistry and Chemical Engineering. He also sits on the advisory board for chemistry and chemical engineering at UC Berkeley, is a member of the American Chemical Society and the American Institute of Chemical Engineers. Banholzer earned a bachelor’s degree in chemistry from Marquette University and master’s and doctorate degrees in chemical engineering from the University of Illinois. He is a certified Six Sigma Master Black Belt, holds 16 U.S. patents and has over 80 publications, which have received more than 1000 citations, for his work in the field of engineering and chemistry.

Independent Non-Executive Director. Dr Burns is Chairman, President and Chief Executive Officer of Dow Corning. She joined Dow Corning in 1983 as a researcher working on water based and high temperature elastomers. She became director of Women's Health in 1994 and subsequently moved into corporate management becoming Science and Technology Director for Europe in 1997. She was first elected to Dow Corning's Board of Directors in December 2000, she was then elected President and Chief Executive Officer in February 2003, Chief Operating Officer in January 2004 and Chairman in January 2006. Dr Burns holds a Ph.D. in organic chemistry, with an organosilicon specialty, from Iowa State University. She completed her post-doctoral studies at the Universite Montpellier, Sciences et Techniques du Languedoc, France. She is a board member of the American Chemical Society and The Conference Board and sits on the Executive Committee of the Society of Chemical Industry, and on the Board of Directors for the Society of Women's Health Research. She has also served on the Michigan Molecular Institute.

Dr. Pearce has served as a member of our board of directors since June 2006. Dr. Pearce served in various capacities at Eli Lilly & Company since joining the company in 1979, including Vice President, Cancer Research and Clinical Investigation from 1994 to 2002 and Fellow, Cancer Research, Lilly Research Laboratories from 2002 to March 2006. Since August 2006, Dr. Pearce has served as a consultant to our company. He is a member of the American Association for Cancer Research, the American Chemical Society and the American Association for the Advancement of Science. He received a B.S. from Texas A&M University and his Ph.D. from Harvard University.

The Waste and Environmental Management Business Unit develops innovative technologies and provides technical services in environmental remediation and mitigation for the fuel production and power production industries. Dr. Bland has over 20 years experience with ash management issues for advanced coal combustion/desulfurization technology ashes. He has authored or co-authored over 50 publications in the areas of waste management and coal cleaning and has presented at many national and international conferences. Dr. Bland serves on the steering committee of the International Conference on Fluidized Bed Combustion and has also served as environmental issues topic coordinator. Dr. Bland is a member of SME/AIME and the American Chemical Society.

Michael joined SCOLR Pharma in 2000 as a formulator and is one of the founding members of the Company's product development group. He is a graduate of Amherst College and is a member of the American Association of Pharmaceutical Scientists (AAPS), the Controlled Release Society (CRS), and the American Chemical Society (ACS). Michael has published multiple articles in peer-reviewed journals, presented numerous poster presentations at the AAPS and CRS national conferences, and is a frequent editorial contributor to numerous pharmaceutical industry publications.

Mr. DiPasquale is responsible for developing NMR, ESR, and Mass Spectrometer sales throughout the United States, Canada, and Mexico. He has 18 years of experience in analytical instruments sales and a strong chemistry background. He received a B.S. and M.S. in Chemistry from Tufts University in Medford, Massachusetts. Memberships include the American Chemical Society, American Society of Mass Spectrometry, Greater Boston and Connecticut Mass Spectrometry Discussion Groups, and Regional NMR Discussion Groups.

Dr. David Albert, A Senior Scientist at NAMSA's Ohio laboratory, holds a Ph.D. in Chemistry, a Doctorate in Podiatric Medicine, and an MS with an emphasis in Biochemistry. His primary expertise is in the areas of pharmacology and biochemistry, with over 25 years of laboratory experience. Dr. Albert has previously been a faculty member in the Department of Chemistry at Lourdes College for over 10 years and an adjunct professor in the College of Pharmacy at the University of Toledo; he has presented and published numerous papers. He is currently a member of the American Association for Clinical Chemistry, the American Chemical Society, AAMI, PDA, and the Ohio Academy of Science. David Parente, Senior Consultant & General Manager of NAMSA Advisory Services, has more than 23 years of experience in the fields of sterilization, biocompatibility, quality systems, and facilities management. He previously served NAMSA clients as a Senior Scientist and Operations Manager of the Georgia laboratory. Prior to joining NAMSA, Mr. Parente held management positions at Terumo Medical Corporation in the areas of biological safety, sterility assurance, irradiator operations, project engineering and regulatory compliance. He is actively involved with AAMI and is a member of working groups ISO/TC 198 and ISO/TC 194.

Jean Parr is the Program Director of the American Chemical Society's (ACS) Member Insurance Program. In this capacity, she directs the development, marketing and administration of the group insurance plans for ACS members and is the Secretary of the Board of Trustees, Group Insurance Plans for ACS Members. Ms. Parr has held a variety of positions at ACS since joining the staff in 1981. Prior to her current posting, she was Head of the Department of Career Services (1997-2002), Staff Liaison to the Society's Committee on Economic and Professional Affairs, and served as a Member of the Board of Directors of the Commission on Professionals in Science and Technology. From 1990-1996, she headed the ACS Membership Activities Department and was the Staff Liaison to the ACS Membership Affairs Committee and the Admissions Committee. She was appointed Chair of the Membership Committee, Council of Scientific and Engineering Society Executives, 1993-1995. She spent the first ten years of her tenure at ACS in the Department of Government Relations and Science Policy. She holds a BS degree in Plant Science from the University of Delaware.

Chuck Gahun received his B.A. in Government and International Politics with a concentration in Comparative and International Politics from George Mason University in 2001. He currently works for the American Chemical Society in their Software Engineering Department as a project manager, where he manages the development of custom software solutions for various business units. In addition to working at the Society, Chuck continues to consult with the National Center Staff on web and project management activities and is enrolled in a graduate program at the School of Management at George Mason University.

Andy Bond is presently a Senior Chemist with the PG Research Foundation. He earned the B.S. degree in Chemistry in December, 1990 and the Ph.D. degree in Chemistry (inorganic emphasis) in May, 1995, both from Northern Illinois University. Andy has been a Postdoctoral Research Scientist with Professor Gregory R. Choppin at The Florida State University (March, 1995-October, 1996), with Eichrom Industries, Inc. (October, 1996-July, 1997), and with the Chemical Separations and Actinide Coordination Chemistry Groups in the Chemistry Division at Argonne National Laboratory (July, 1997-July, 2000). Andy is currently a member of American Chemical Society (1989-Present), American Nuclear Society (1998-Present) and the Society of Nuclear Medicine (2000-Present). His professional activities include Program Committee membership for the Separation Science and Technology Subdivision of the ACS Division of Industrial and Engineering Chemistry (1995-Present) and he served for five years as the Division of Industrial and Engineering Chemistry Poster Session Organizer (1996-2001). Andy has also served as the Secretary of the Separation Science and Technology Subdivision (1998-2000) and is now the Vice Chair Elect. Andy coorganized two symposia resulting in an ACS Symposium Series book coedited with Dr. Mark L. Dietz and Dr. Robin D. Rogers entitled "Metal Ion Separation and Preconcentration: Progress and Opportunities" (1999) and a special Applied Chemistry section in Industrial and Engineering Chemistry Research (2000) arising from a symposium entitled "Nuclear Separations for Radiopharmacy". Andy has authored or coauthored 50 publications in 23 different journals (12 of which appear in five different ACS journals), three review articles, four chapters in books, four contributions to symposium proceedings, and three patents. In addition, Andy has authored or coauthored 79 presentations at national or international meetings, 15 at regional meetings, and he has presented three invited seminars. Andy's research experiences include separation science, solvent extraction, ion exchange, extraction chromatography, synergistic extraction, coordination chemistry, solution chemistry, radiochemistry, hydrometallurgy, radiopharmacy, actinide chemistry, structural chemistry, synthetic inorganic and organic chemistry, and environmental chemistry.

Dr. Robaugh joined Pyxant Labs Inc in August 2002 as Vice President. He has more than 17 years experience leading GLP studies, and more than 25 years experience in the development and application of state-of-the-art analytical techniques including LC/MS, MS-MS techniques, GC/MS, MALDI-TOF, and FAB. Moreover, Dr. Robaugh has extensive experience leading original research projects over a wide range of topics, including picogram-level bioanalytical method development, ADME, PK/PD, metabolism, toxicology bioanalytical support, and a wide range of sample preparation experience. His specialties include: pre-clinical drug development, HPLC/MS, MS-MS, trace-level bioassays, bioanalytical method development and validation (urine, plasma, serum, and various tissues), method troubleshooting, mass spectrometry, project management, experimental design, GLP, cGMP, and OECD regulated studies. Former positions included Midwest Research Institute, Kansas City. Dr. Robaugh's education highlights are a B.S. in Chemistry, California State University of Pennsylvania and Ph.D., Physical Chemistry, West Virginia University. Dr. Robaugh's professional affiliations include being a member of the American Chemical Society, the American Association of Pharmaceutical Scientists, and the Rocky Mountain Regional Chapter Society of Quality Assurance.

Dr. Donna Visioli joined DuPont as a polymer scientist in 1984 and spent more than 15 years delving into research projects involving packaging materials like water-soluble polymers, barrier resins and ethylene copolymers. After acquiring significant expertise in food chemistry, Visioli began to concentrate on food packaging applications and how innovative packages can offer safer, fresher, healthier, more varied choices in environmentally friendly containers that boost consumer convenience and flexibility. Visioli and her colleagues have taken great strides in packaging perishables like meat and produce so that they are "case ready," or shipped to stores already packaged for final sale. She and her team helped develop state-of-the-art packages that securely seal meat, but at the same time allow oxygen in to retain the tempting red color consumers expect. They helped design packages that hold marinated meat products without leaking, even though marinades often contain abrasive spices like peppercorns that would pierce many packaging films. She and her team also are evaluating several exciting applications for perishable foods that will set new standards for freshness and long shelf life. Visioli works with the U.S. Food and Drug Administration, the U.S. Department of Agriculture, universities and food processors to help create safer, more effective food packaging. A prolific author of numerous scientific articles, Dr. Visioli holds more than 15 U.S. patents and 50 international patents. She actively participates in many industry associations, such as the National Food Processors Association, the American Chemical Society, the Technical Association of the Pulp and Paper Industries, and the Institute of Food Technologists.

Dr. Goodrich is currently Chief Science Officer and his responsibilities include oversight of research, protocol development, toxicology, and validation programs. Dr. Goodrich has worked in the blood industry for 17 years during which he has managed technical staff and development programs in the fields of blood preservation and pathogen reduction technologies. He has been awarded 34 patents in the U.S. covering technology in these areas and has published over 70 articles and abstracts in the field of blood chemistry and biology. He currently serves as the Principal Investigator for Navigant's grants from the Department of Defense. Dr. Goodrich has also been actively involved in the development of entrepreneurial organizations from a consulting and advisory role. He is frequently called upon as an invited speaker on the topic of pathogen reduction of blood products throughout the U.S., Europe, and Japan and is an active member of several professional organizations including the American Chemical Society, the Southern California Entrepreneurship Association, the American Association of Blood Banks, the American Society of Hematology, the American Society of Photobiology, and the Parental Drug Association. Most recently, Dr. Goodrich was appointed an Adjunct Professor of Chemistry at Ohio State University.

Irv Kraut completed his college education at the University of Illinois. Irv has attended specialized educational courses provided by the Department of the Army at Redstone Arsenal, the ATF, FBI and the National Association of Mold Professionals. Irv has also trained government employees for the United States Environmental Agency (EPA), Department of Defense and the Department of Energy and he has conducted training in the corporate sector for companies such as Monsanto, Abbott Laboratories, Johnson & Johnson and Service Master. Additionally, educational facilities including The University of California at San Diego and Santa Barbara have requested his consultation services. Irv is a contributing author for the United States Environmental Protection Agency (EPA) and the American Chemical Society. He was also recently appointed to the Board of Collier County Commissioners to serve on the Environmental Advisory Council (EAC) in Naples, Florida. The EAC acts in an advisory capacity to the Board of Collier County Commissioners on matters dealing with the regulation, control, management, use or exploitation of any or all natural resources within the County. The EAC is also required to review and evaluate specific zoning and development petitions with regards to their impact on natural resources. In addition to his role as VP of Sales and Marketing at Infrared Consultants, due to his 30 years of expertise in the environmental field, Irv acts as our Senior Environmental Inspector. He works in conjunction with our research lab to develop new and innovative products for the indoor air quality industry. Irv also provides training and educational support to our team of inspectors.

Jim Bell joined Food Safety Net Services in 2005 as the Director of Laboratory Operations. Before joining FSNS, Jim worked for over 25 years in different food and agricultural testing laboratories and has experience in the fields of microbiology, analytical chemistry, laboratory management, regulatory compliance, and research. Jim earned his Bachelor of Science degree in Microbiology with a minor in Chemistry from The University of Memphis and has completed some post graduate course work in Chemistry at Middle Tennessee State University. He is a member of numerous organizations such as IAFP, AOAC International, American Chemical Society, IFT, American Society for Quality, and the American Oil Chemists Society. Jim also has attended many workshops and short courses through AOAC and ISO in order to enhance his knowledge and abilities in the laboratory.

Mark Henry has a broad technical background with degrees in both chemical engineering and electrical engineering. He has a bachelors degree in chemical engineering from the Pennsylvania State University and a master's degree in electrical engineering from the George Washington University. In addition to extensive coursework in circuit theory, signal processing, organic chemistry and physical chemistry, he has studied telecommunications, biochemistry and material science. He has used this diverse background to focus on cross-over technologies such as microelectronics and semiconductor physics. Mr. Henry attended law school at Widener University and Catholic University. Mr. Henry is admitted to the bars of the District of Columbia, Virginia and New Jersey and to practice before the U.S. Patent and Trademark Office. He has also passed the qualifying exam for professional engineering certification. Before joining Staas and Halsey, Mr. Henry worked for the Westinghouse law department, writing mechanical and chemical patent disclosures for nuclear processing and other energy technologies. He also worked for the U.S. Patent and Trademark Office, examining patent applications in the fields of adhesive materials and various chemical manufacture. Mr. Henry is experienced in virtually all aspects of patent procurement from developing a strategy regarding where to file and which claims to present, to appealing before the Court of Appeals for the Federal Circuit. Mr. Henry is also experienced in complex post-allowance correction proceedings. He has lectured on post-allowance correction and presented seminars on claim drafting. His work in patent procurement has been in a wide range of technical arts including semiconductor device electronics, organic and inorganic chemistry, wireless communication, polymer processing, optical communication and telecommunication. Mr. Henry has worked with clients in conducting infringement and validity studies. He has used these studies to conduct licensing and settlement negotiations and to counsel clients during litigation. Mr. Henry has also drafted complex patent licensing, product development and confidentiality agreements. Mr. Henry is the author of "State Courts Hearing Patent Cases: A Cry for Help to the Federal Circuit," Dickinson Law Review, reprinted in Intel. Prop. Today, "USPTO Reverses Policy on 'Bypass Continuation' Applications," Intel. Prop. Today, and "'Technical' Amendments to 35 U.S.C. 102(e): Another Instance of the Doctrine of Unintended Consequences?" Intel. Prop. Today. Mr. Henry is also a member of the American Intellectual Property Law Association, the Patent and Trademark Office Society and the American Chemical Society.

Maurice is President, Chief Executive Officer, and principal investor in the corporation. He is responsible for business development and customer relations, oversight of operations, and human resources. Maurice has more than 18 years experience in the chemical industry, including large-scale manufacturing, technology development, environmental compliance, managerial, and business intelligence roles at Dow Chemical. His educational foundation includes a B.S. in Chemical Engineering, Magna Cum Laude, from Texas A&M University and a M.B.A., University of Houston, Clear Lake, TX. Professional Affiliations include American Institute of Chemical Engineers, American Chemical Society, and American Association of Pharmaceutical Scientists.

Mohamed was called to the bar in 2006 and has joined the civil litigation department. His areas of practice include personal injury, insurance defence, medical malpractice, and class actions. He is a member of the Ontario Bar Association, the Canadian Bar Association, and the Middlesex Law Association. Mohamed attended the University of Western Ontario where he obtained an Honours Bachelor of Science in Chemistry in 1989 and a Doctor of Medicine in 1995. Mohamed has co-authored or contributed to papers published by the Ontario Ministry of Environment, the American Chemical Society, and the journal Ophthalmology. In 2005, Mohamed graduated from U.W.O. with a Bachelor of Laws degree. Mohamed completed his articles at Cohen Highley. Born and raised in London, Mohamed has a keen connection to the London community. He has been involved in property development, commercial rental property, and multi-family residential rental properties. He also presently raises horses as well as beef cattle at the outskirts of the city. Your use of this website constitutes acceptance of the Cohen Highley LLP Terms & Conditions.

Bob Beffa is responsible for managing the Quality Assurance and Regulatory Affairs at Cambridge Major. He has a broad range of experience in developing, maintaining, and implementing GMP documentation and control from initial clinical materials through commercialization of Active Pharmaceutical Ingredients. Over his career, he has authored and successfully filed a dozen Drug Master Files, and has contributed to dozens of IND and NDA submission documents. He has also participated in numerous successful FDA and client audits of the Company's facilities. He is an active member in the American Chemical Society (ACS), and the American Society for Quality (ASQ). Prior to joining CML, Bob worked for the startup company, Major Laboratories where he was a production chemist. As such Bob brings tremendous perspective to the Quality Unit as he understands the chemistry behind the documentation.

Ron is a partner in Cameron and Associates, a consulting firm focused on corporate venturing through technology and innovation. He is also a member of the Radical Innovation Group, a consulting firm that works with global companies to develop their innovation capability. Ron is a professor at Wharton and Lehigh University Business Schools. He is also a member of the faculty for the program on Corporate Entrepreneurial Leadership at the Danish Technical University. He is also on the board of directors of Primet Precision Materials, Inc. in Ithaca NY.

Dr. Bostick is the technical director for MCLinc. He received a B.A. degree from Vanderbilt University (chemistry) and a Ph.D. degree from the University of Georgia (analytical chemistry). He has over 30 years of experience in technical areas that include instrumentation development, separation science, spectroscopy, bioanalytical chemistry, hazardous and radiological waste treatment and waste stabilization, thermal treatment technologies, and regulatory and compliance issues. In 1990, he received a Martin Marietta technical achievement award for "outstanding insight and initiative in individual and leadership contributions in the waste management program," and in 1991, staff members received an R&D100 award for development of a process to recycle electrode-less nickel plating baths. Dr. Bostick has authored or co-authored over 130 publications and formal technical reports, and has three U.S. patents and five government-owned patent applications. He is a recognized expert in uranium chemistry, in-situ stabilization, and nuclear waste treatment.

Dr. Witczak has extensive industrial experience, as well as academic experience in carbohydrates. His work on levoglucosenone and its utilization to the synthesis of various classes of rare sugars led him to study the entire field to explore the hidden potential of this universal carbohydrate building block by expanding its application to medicinal chemistry of carbohydrates. His developments have made it possible to synthesize new classes of compounds important in biology and medicine (thiosugars, aminosugars) as potential therapeutics directly from levoglucosenone and have pointed the way toward new methods for use in large-scale chemistry. Dr. Witczak is a regular speaker at national and regional American Chemical Society (ACS) meetings, as well as International Carbohydrate Society meetings. In 2002, he chaired the Division of Carbohydrate Chemistry of the ACS and is the current chair of its award committee. He has lectured in numerous research institutions and has published more than 60 research papers and patents in the field of carbohydrate, medicinal and biological chemistry. In 1997, Dr. Witczak co-edited with Karl A. Nieforth a book entitled Carbohydrates in Drug Design, which has since become the leading reference in the field. In addition he has edited three books and is a guest editor for carbohydrate topics of the world-renowned journal, Current Organic Chemistry, and serves on the editorial boards of the Journal of Carbohydrate Chemistry, Current Medicinal Chemistry and The Investigational Drugs Journal. In 2000, Dr. Witczak was awarded the Melville L. Wolform Award of the ACS, Division of Carbohydrate Chemistry for his outstanding research contribution to carbohydrate chemistry and service to the Division. In 1997, he received the John S. Burlew award from the Connecticut Valley Section of the ACS for his outstanding contribution to carbohydrate chemistry. Dr. Witczak was educated in Lodz, Poland, receiving his M.S. and Ph.D. degrees from the Medical University of Lodz. He worked at Purdue University as a postdoctoral fellow with Professor Roy L. Whistler, a world-renowned authority in carbohydrate chemistry.

A. Wallace Hayes, PhD, DABT, FATS, FIBiol, FACFE, ERT, Hayes is a toxicologist with over 30 years of experience. He has written over 200 peer reviewed publications and is the editor of the textbook, Principles and Methods of Toxicology, the international journal of Human and Experimental Toxicology and a co-editor of the Target Organ Toxicity Series. Dr. Hayes also is the editor of Cutaneous and Ocular Toxicology. Before joining Harvard School of Public Health as a visiting scientist, Dr. Hayes was Vice-President of Corporate Product Integrity at the Gillette Company, where he had management responsibility for the safety evaluation of a variety of consumer products, plant safety, environmental stewardship, and quality control. Dr. Hayes is an adjunct Professor at Wake Forest University School of Medicine, the University of Louisville School of Medicine and the School of Public Health, the University of Massachusetts. Dr. Hayes holds degrees from Auburn University (PhD and M.S.) and Emory University (A.B.). Dr. Hayes was an NSF predoctoral fellow at Auburn University, a NIH postdoctoral fellow at the Vanderbilt University School of Medicine, and a NATO Senior Scientist at the Central Veterinary Laboratory, Weybridge, England. Dr. Hayes currently lectures at the Harvard School of Public Health and at Virginia Polytechnic and State University and in the Risk Assessment Summer School of the International Union of Toxicology (IUTOX). Dr. Hayes has served the International Union of Toxicology as the editor of the Proceedings of ICT III (Developments in the Science and Practice of Toxicology) and as the editor of the Proceedings of the 5th Congress of Toxicology in Developing Countries (Toxicology in the New Century Opportunity and Challenge). He has served as a delegate to IUTOX and on several IUTOX commissions. Dr. Hayes currently is the Secretary-General of IUTOX and a member of the council of the American College of Toxicology. Dr. Hayes has served on committees and expert panels for the National Academy of Sciences, the National Institutions of Health, the Environmental Protection Agency and the Department of Defense. Dr. Hayes is a diplomat of the American Board of Toxicology, The Academy of Toxicological Sciences, the American Board of Forensic Medicine and the American Board of Forensic Examiners. He is a Fellow of the Academy of Toxicological Sciences, the Institute of Biology (UK) and the American College of Forensic Examiners. Dr. Hayes is a registered toxicologist in the European Union (ERT) and a certified nutrition specialist.

Andreja Bakac is an adjunct professor in the Department of Chemistry at Iowa State University and a senior scientist with Ames Laboratory, a Department of Energy facility. Her research interests include kinetics and mechanisms of inorganic and organometallic reactions; catalytic oxidation with molecular oxygen; activation of dioxygen by transition metal complexes; and chemistry of reactive intermediates in transition metal-dioxygen interactions. Bakac currently serves on the editorial board of the following science publications, Inorganic Chemistry, Inorganic Reaction Mechanisms, and Dalton Transactions. She is a member of the American Chemical Society, American Association for the Advancement of Science, Sigma Xi, and the Iowa Academy of Science. In 1988 and 1990 she was a visiting professor at Tohoku University in Sendai. Bakac received her B.S. and her Ph.D. from the University of Zagreb. She completed her postdoctoral work at Iowa State University with Jim Espenson, professor of Chemistry, before joining Ames Laboratory.

Andrew holds a B.S. in Chemistry and an M.S. in Chemistry from Wichita State University. Andrew is a member of the American Chemical Society and holds Master's Certification in the following areas: Physical, Analytical, Organic, Inorganic, Electrical, and Biochemical chemistry. Andrew has spent the last five years teaching at Our Lady of Tepeyac High School in Chicago. He teaches a variety of mathematics and science classes, including AP Calculus, Physics, and Chemistry. Andrew has been the Department Chairperson in Math and Science since 2002 and is also the National Honor Society Induction Committee Chairperson and the Advanced Placement College Board Coordinator. Instructor in mathematics, verbal, and writing for a variety of standardized tests and mathematics and science for academic subjects.

Anne is an analytical chemist with a broad-range of expertise in chromatography, mass spectrometry, and GC-MS. At TEI, she focuses on the development and applications of analytical techniques and systems in the areas of environmental chemistry (air and water), petroleum chemistry, industrial cleaning chemistries and equipment, and process and product development. She also has extensive experience in the characterization/speciation of complex mixtures for petroleum products, flavor/fragrance products, and ambient, stationary source or indoor air. Anne holds a master of science in analytical chemistry from the University of Illinois Urbana-Champaign. Prior to joining TEI, she served as manager of product and process chemistry, analytical development, for Safety-Kleen, Inc. She is a member and past president of the Chicago Chromatography Discussion Group, and a member of the MCM Mass Spectrometry Discussion Group, American Chemical Society, Sigma Xi, and the American Society for Mass Spectrometry.

Art Springsteen is the president and chief technical officer of Avian Technologies, LLC. Avian Technologies specializes in the design and manufacture of instruments and standards for optical spectometry and other optical radiation measurements. Prior to starting Avian Technologies in 1999, Dr. Springsteen was Principal Scientist and Director for Advanced Development at Labsphere,Inc. for 13 years. During his tenure at Labsphere, he developed over 30 commercial products, including the Spectralon diffuse reflectance material product line, numerous optical coatings, fluorescent materials and accessories for measurement of reflectance, diffuse transmittance and fluorescence. He holds five U.S. patents (and has three pending) on materials and instrument design, won a 1990 Photonics Spectra New Product of the Year award (Optical Grade Spectralon), and shared another in 1997 for the development of the Labsphere bispectral fluorescence colorimeter. He has published over thirty scientific papers and may often be seen in the pages of Spectroscopy Magazine's "Spectroscopy Workbench"' section. He is also co-author/editor (with Jerry Workman) of the Academic Press book "Applied Spectroscopy, A Complete Guide for Practitioners," has edited the Proceedings of the Third and Fourth Oxford Conferences on Spectrometry. He is also a member and former Secretary for the Council for Optical Radiation Measurement, a member of the Board of Directors of the Inter Society Color Council, and a former member of the National Research Council of the U.S. He is also an active member of ASTM Committees E-12 (Color and Appearance) and E-13 (Molecular Spectroscopy), the Society for Applied Spectroscopy, and Council for Near-Infrared Spectroscopy. He holds a Ph.D. from West Virginia University in Organic Chemistry.

Dr. Meinhart is the Director of Analytical Instruments (NMR, Mass Spec and ESR) and is responsible for product management, coordinating operations, managing the applications staff and participating in new product development. Prior to joining JEOL 20 years ago, Doug received his B.S. in Chemistry from the University of Rochester in 1981, Ph.D. in Chemistry from the California Institute of Technology in 1987, and completed post-doctoral studies at the University of Chicago. He is also a member of the American Chemical Society.

Dr. Lecon ( Lee ) Woo was trained in chemical physics from the University of Chicago. To date, he has been named inventor or co-inventor in 51 patents on medical devices, materials, and processes while contributing more than 150 technical articles and 12 book chapters to his professional societies. He is a fellow of the Society of Plastics Engineers, member of American Chemical Society, American Institute of Physics, AAAS, and Sigma Xi. Lee Woo started his professional career with E. I. Dupont working on polymer characterization techniques with an R&D-100 Award winning Dynamic Mechanical Analyzer (DMA) to his credit. Prior to joining Baxter Healthcare, he conducted research on polyolefins, thermoplastic elastomers, and adhesives at the ARCO Chemical Company. In 1984, he was appointed technical director at Baxter's corporate Material and Membrane Technology Center, and in 24 years of service at Baxter, he and his teams resolved numerous important issues, and invented new materials, processes and devices. In the mid-80's, he discovered that many rigid plastics devices become brittle due to a phenomenon called physical aging, and found ways to prevent it. The spider diagram he used to graphically analyze product performance is now the standard practice for major companies. In 1992, he became the first person appointed to the position of Baxter Distinguished Scientist, and currently holds the position of Distinguished Scientist Emeritus.

Donald S. Mueller is Vice President and Chief Innovation Officer, USG Corporation. Dr. Mueller received a Bachelor's degree in chemistry from Hiram College and a PhD in chemistry from the University of Illinois. His previous assignment includes Vice President, Research and Technical Innovation, USG Corporation. He joined USG Corporation in 2005 as Vice President, Research and Development, USG Corporation. Prior to joining USG, Dr. Mueller was Director, Industry and State Relations for the Environmental Science Institute at The Ohio State University and Vice President and Chief Technology Officer, Ashland Specialty Chemical Co. Dr. Mueller has also held senior level and technical positions at Rohm & Haas and Johnson & Johnson. Dr. Mueller has been active in several professional associations including the Council for Chemical Research, the American Chemical Society and the Industrial Research Institute, where he has served as Chairman and as a member of the Board of Directors.

"John C. Lechleiter, Ph.D, is chairman, president and chief executive officer of Eli Lilly and Company. Lechleiter chairs the company’s operations committee, as well as its executive committee. Lechleiter served previously as president and chief operating officer of Lilly, beginning in 2005, when he also joined the board. In 2004, he became Lilly’s executive vice president, pharmaceutical operations. Prior to that, he had served as executive vice president for pharmaceutical products and corporate development since 2001. Lechleiter received a bachelor of science degree summa cum laude in chemistry from Xavier University (Cincinnati, Ohio) in 1975. He studied organic chemistry as a National Science Foundation Fellow at Harvard University, where he received his master’s and doctorate degrees. In 2006, Lechleiter received an honorary doctorate of business administration from Marian College of Indianapolis. Joining Lilly in 1979 as a senior organic chemist in process research and development, Lechleiter became head of that department in 1982. In 1984, he began serving as director of pharmaceutical product development for the Lilly Research Centre Limited in Windlesham, England. He returned to the United States in 1986 as manager of research and development projects for Europe. In 1988, he became director of development projects management, and in 1989 he assumed additional responsibility for pharmaceutical regulatory affairs. In 1991, he was named executive director of pharmaceutical product development, and in 1993, he became vice president. He was appointed vice president of regulatory affairs in 1994. In 1996, he was named vice president for development and regulatory affairs. Lechleiter became senior vice president of pharmaceutical products in 1998. Lechleiter is a member of the American Chemical Society. He serves as a member of the Executive Committee of the Board of Directors of Pharmaceutical Research and Manufacturers of America (PhRMA) and as a member of the Business Roundtable and the Business Council. In 2004, he was appointed to the Visiting Committee of Harvard Business School and to the Health Policy and Management Executive Council of the Harvard School of Public Health. He also serves as a member of the board of trustees of Xavier University (Cincinnati, Ohio). In addition, he is a distinguished advisor of The Children’s Museum of Indianapolis, a member of the board of directors and executive committee of Fairbanks Institute, and a member of the United Way of Central Indiana board of directors. He also serves on the board of Indianapolis Downtown, Inc. "

Paul S. Weiss, PhD is an Associate Professor of Chemistry at The Pennsylvania State University, where he began his academic career as an assistant professor in 1989. He received his S.B. and S.M. degrees in chemistry from MIT in 1980 and his PhD in chemistry from the University of California at Berkeley in 1986, working with Prof. Yuan T. Lee on crossed molecular beam reactions of excited atoms. He was a post-doctoral member of technical staff at Bell Laboratories from 1986-1988 and a Visiting Scientist at IBM Almaden Research Center from 1988-1989. He was a Visiting Professor at the University of Washington, Department of Molecular Biotechnology from 1996 1997, and at the Kyoto University, Electronic Science and Engineering Department and Venture Business Laboratory in 1998 and 2000. He is the founder and CEO of Atolytics, Inc., a company devoted to developing and commercializing atomic-scale imaging and spectroscopy techniques and instruments. He has published over 100 scientific publications and patents and has given over 200 invited and plenary lectures. Since joining Penn State, Weiss has been awarded a National Science Foundation Presidential Young Investigator Award (1991 1996), the Scanning Microscopy International Presidential Scholarship (1994), the B. F. Goodrich Collegiate Inventors Award (1994), an Alfred P. Sloan Foundation Fellowship (1995 1997), the American Chemical Society Nobel Laureate Signature Award for Graduate Education in Chemistry (1996), and a John Simon Guggenheim Memorial Foundation Fellowship (1997). He was recently elected a Fellow of the American Association for the Advancement of Science (2000). Weiss has served on numerous federal advisory boards and conference organizing committees. At Penn State, he is a member of the Interdisciplinary Solid State Program, the National Science Foundation Glass Center, and the Membrane Transport Group of the Biotechnology Institute. He is on the Executive Board of the Center for Materials Physics and on the Advisory Board of Alpha Chi Sigma, the chemistry honor fraternity. He currently serves on the U.S. National Committee to the International Union of Pure and Applied Chemistry. He is a member of the American Chemical Society, the American Physical Society, the American Vacuum Society, Sigma Xi, and the Society of Analytical Chemists of Pittsburgh.

Richard is Executive Director of the AMTEX Partnership, a Research and Development collaboration between the integrated textile industry and the laboratories of the United States Department of Energy. He assumed this position in 1993. Born in Springfield, IL, Richard was graduated from Millikin University in 1956 and received a Doctor of Philosophy degree in chemistry from the University of Utah in 1961. Before assuming the AMTEX position, he was Vice President for Research at the DuPont Company where he was responsible for Corporate R & D activities. He was responsible for DuPont's long-range programs in chemistry, physics, materials science, biology and computation. Richard is a member of the American Chemical Society, the American Association for the Advancement of Science, and the New York Academy of Science. He is Vice President of the Board of Trustees of the University of Delaware Research Foundation, a member of the Board of Governors of the University of Chicago for the Argonne National Laboratory, chairs the Science and Technology Advisory Committee for Argonne, and is on the Review Committee for the Technology and Safety Analysis Division, Los Alamos National Laboratory.

Benjamin R. Yerxa, Ph.D. has served as our Chief, Scientific Operations and Alliances since December 2005. Prior to that, he held the position of Senior Vice President, Discovery since March 2003. Dr. Yerxa joined Inspire in August 1995 and has held several positions, including Vice President, Discovery and Senior Director of Preclinical Programs. Dr. Yerxa created a novel strategic opportunity for Inspire by developing the concept of ophthalmic uses for Inspire s core P2Y2 technology. As a Senior Research Chemist his work focused on designing and synthesizing novel P2Y receptor agonists, such as diquafosol. While in chemistry, he was the preclinical project leader for diquafosol. In 2004, Dr. Yerxa received the Southeastern Region American Chemical Society (ACS) Industrial Innovation Award for discoveries related to his work with P2Y2 receptors. Dr. Yerxa received the Triangle Business Journal s 40 under 40 award, recognizing his contributions in business and leadership. He was also a finalist for Ernst & Young s Entrepreneur of the Year in NC 2003. Prior to joining Inspire, Dr. Yerxa was a Research Scientist at Burroughs Wellcome. Dr. Yerxa also worked at Biophysica, Inc. where he synthesized radiocontrast agents. He developed scale-up procedures for the industrial production of Oxilan, a marketed imaging product. Dr. Yerxa received a B.A. in Chemistry from the University of California, San Diego, and a Ph.D. in Organic Chemistry from the University of California, Irvine.

J. Zach Hilt is an Assistant Professor of Chemical Engineering in the Department of Chemical and Materials Engineering at the University of Kentucky. Prof. Hilt received his bachelor degrees in Chemistry and Physics from Miami University (Ohio). He completed his Masters degree in Chemical Engineering from Purdue University and his Doctor of Philosophy in Chemical Engineering from the University of Texas at Austin. Prof. Hilt's research laboratory focuses on the design of novel hydrogel biomaterials, the development of novel methods to synthesize and characterize the hydrogels at the micro- or nanoscale, and the application of these materials as biomedical devices or functional components of biomedical devices. Prof. Hilt has authored numerous referred publications, including a recent review "Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology" published in Advanced Materials. He is co-editor of "Nanotechnology in Therapeutics: Current Technology and Applications" which is published by Horizon Scientific Press and is one of the first books dedicated to the topic of nanotechnology in drug delivery. Prof. Hilt was an invited participant in the 2008 German-American Frontiers of Engineering Symposium (GAFOE), which was co-organized by the National Academy of Engineering (NAE) and the Alexander von Humboldt Foundation. He is a member of the Materials Research Society, American Institute for Chemical Engineers, Society for Biomaterials, American Chemical Society, and the Controlled Release Society. He has taken an active role in these professional societies, including co-organizing the Bionanotechnology Topical Conference at the Annual AIChE Meeting for the past few years.

Mr. Black, has over 31 years of corporate executive experience. He spent seven years as an Air Force officer, rising to the rank of Captain before moving into private industry. Mr. Black is a Registered Professional Engineer. He has earned BS in Chemistry (Pennsylvania State University '61), MS in Electrical Engineering (University of Missouri '66), and an MBA, Finance (University of Akron '82). Mr. Black is a member of the American Chemical Society, and holds 14 US Patents issued, with additional US and foreign patents issued and pending. Mr. Black, the inventor and marketer of Clean Shower, is the founder of Automation, Inc., and the General Partner of Clean Shower LP. He is also a part owner of Hydrochem Systems, Inc., where he developed and managed a plan to have them acquired in an earn-out, which includes a substantial guarantee. Mr. Black's wide range of professional and career experience includes President of Somark International, President of Automation, Inc., Technical Manager of the BF Goodrich Marine and Missile Products Division and Manager of Manufacturing for the Ohio Brass Division of the Hubbell Corporation.